Exploring a novel class tryptophan hydroxylase 1 inhibitor derived from Sambucus williamsii Hance for the osteoporosis treatment

Abstract

Objective: Gut-derived serotonin strongly inhibits bone formation by inhibiting osteoblast proliferation. Our previous study demonstrated that the lignan-rich fraction prepared from Sambucus willimasii Hance, a folk herbal medicine used to treat bone fractures and joint diseases in China, exerted bone-protective effects, and its actions were modulated by suppressing the synthesis of gut-derived serotonin via the inhibition of intestinal tryptophan hydroxylase 1 (TPH-1). However, there is no direct evidence for the action of lignans on TPH-1. This study aimed to verify the direct action of lignans on the TPH-1 and its influence on serotonin synthesis and bone properties.
Methods: Molecular docking and surface plasmon resonance were performed to determine the affinities of lignans to TPH-1. The cell viability and the protein activity and expression of TPH-1 were measured in RBL2H3 cells. The serum serotonin level and bone mineral density upon lignan treatment in ovariectomized mice were determined.
Result: The lignans showed high binding scores and binding affinities to TPH-1, inhibited the activity and protein expression of TPH-1, suppressed the serum serotonin levels in ovariectomized mice as well as promoted bone mineral density.
Conclusion: This is the first study to report that lignans are novel TPH-1 inhibitors and that these lignans could be potential agents for the management of serotonin-related diseases, including osteoporosis.

Keywords

Lignan / Osteoporosis / Sambucus williamsii Hance / Serotonin / TPH-1 inhibitor

References

[[1]] Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet 2019;393(10169):364-376.

[[2]] Zhang ND, Han T, Huang BK, et al.Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery. J Ethnopharmacol 2016;189:61-80.

[[3]] The Editorial Committee of Chinese Herbals. Chinese Bencao. China, Shanghai: Shanghai Science and Technology Press; 2000:544-546.

[[4]] Xiao HH, Dai Y, Wan HY, et al.Bone protective effects of bioactive fractions and ingredients in Sambucus williamsii HANCE. Br J Nutr 2011;106(12):1802-1809.

[[5]] Xiao HH, Sham TT, Chan CO, et al.A metabolomics study on the bone protective effects of a lignan-rich fraction from Sambucus williamsii ramulus in aged rats. Front Pharmacol 2018;9:932-932.

[[6]] Zhang Y, Li Q, Wan HY, et al.Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. Osteoporos Int 2011;22(2):703-709.

[[7]] Xiao HH, Zhu YX, Lu L, et al.The lignan-rich fraction from Sambucus williamsii Hance exerts bone protective effects via altering circulating serotonin and gut microbiota in rats. Nutrients 2022;14:4718.

[[8]] Spohn SN, Mawe GM.Non-conventional features of peripheral serotonin signalling—the gut and beyond. Nat Rev Gastroenterol Hepatol 2017;14(7):412-420.

[[9]] Yano J, Yu K, Donaldson G, et al.Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015;163(1):258.

[[10]] Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: tryptophan's metabolites in exercise, inflammation,mental health. Science2017;357(6349):eaaf9794.

[[11]] Tan L, Yu JT, Tan L.The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. J Neurol Sci 2012;323(1):1-8.

[[12]] Wu W, Nicolazzo JA, Wen L, et al.Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PLoS One 2013;8(4):e59749-e59749.

[[13]] El Refaey M, Watkins CP, Kennedy EJ, et al.Oxidation of the aromatic amino acids tryptophan and tyrosine disrupts their anabolic effects on bone marrow mesenchymal stem cells. Mol Cell Endocrinol 2015;410:87-96.

[[14]] Karsenty G, Ducy P, Yadav VK, et al.Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med 2010;16(3):308-312.

[[15]] Fu HJ, Zhou YR, Bao BH, et al.Tryptophan hydroxylase 1 (Tph- 1)-targeted bone anabolic agents for osteoporosis. J Med Chem 2014;57(11):4692-4709.

[[16]] Yadav VK, Balaji S, Suresh PS, et al.Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med 2010;16(3):308-312.

[[17]] Xiao HH, Gao QG, Ho MX, et al.An 8-O-4ʹ norlignan exerts oestrogen-like actions in osteoblastic cells via rapid nongenomic ER signaling pathway. J Ethnopharmacol 2015;170: 39-49.

[[18]] Wang YF, Xu ZK, Yang DH, et al.The antidepressant effect of secoisolariciresinol, a lignan-type phytoestrogen constituent of flaxseed, on ovariectomized mice. J Nat Med 2013;67(1):222-227.

[[19]] Yin J, Tezuka Y, Subehan, et al. In vivo anti-osteoporotic activity of isotaxiresinol, a lignan from wood of Taxus yunnanensis. Phytomedicine 2006;13(1):37-42.

[[20]] Xiao HH, Zhang Y, Cooper R, et al.Phytochemicals and potential health effects of Sambucus williamsii Hance (Jiegumu). Chin Med 2016;11(1):36.

[[21]] Quartieri A, García-Villalba R, Amaretti A, et al.Detection of novel metabolites of flaxseed lignans in vitro and in vivo. Mol Nutr Food Res 2016;60(7):1590-1601.

[[22]] Xie F, Wu CF, Zhang Y, et al.Increase in bone mass and bone strength by Sambucus williamsii HANCE. Biol Pharm Bull 2005;28(10):1879-1885.

[[23]] Liu Q, Yang Q, Sun W, et al.Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. J Pharmacol Exp Ther 2008;325(1):47-55.

[[24]] Lavoie B, Lian JB, Mawe GM.Regulation of bone metabolism by serotonin. Adv Exp Med Biol 2017;1033:35-46.

[[25]] Warden SJ, Fuchs RK.Do selective serotonin reuptake inhibitors (SSRIs) cause fractures? Curr Osteoporos Rep 2016;14(5):211-218.

[[26]] Rizzoli R, Cooper C, Reginster JY, et al.Antidepressant medications and osteoporosis. Bone 2012;51(3):606-613.

[[27]] McCabe LR, Parameswaran N. Understanding the Gut-Bone Signaling Axis: Mechanisms and Therapeutic Implications. vol 1033. Cham: Springer International Publishing AG; 2017.

[[28]] Inose H, Zhou B, Yadav VK, et al.Efficacy of serotonin inhibition in mouse models of bone loss. J Bone Miner Res 2011;26(9):2002-2011.

[[29]] Ji LH, Zhao TB.The stimulating effect of pentacyclic triterpenes on bone formation. Chin J Osteoporos 2017;23(3):357-362.

[[30]] Chen DQ, Wu XQ, Chen L, et al.Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription. Ther Adv Chronic Dis 2020;11:2040622320962648.

RIGHTS & PERMISSIONS

2024 Acupuncture and Herbal Medicine